Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis (SIMCOMBIN) ClinicalTrials.gov, 14 Oct 2010 Accessed on 21 May 2014 from http://www.clinicaltrials.gov/ct2/show/NCT00492765. CommentRecommendBookmarkWatch